Literature DB >> 7799957

Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.

X Guo1, Y P Zhang, D A Mitchell, D T Denhardt, A F Chambers.   

Abstract

The role of RAS in transducing signals from an activated receptor into altered gene expression is becoming clear, though some links in the chain are still missing. Cells possessing activated RAS express higher levels of osteopontin (OPN), an alpha v beta 3 integrin-binding secreted phosphoprotein implicated in a number of developmental, physiological, and pathological processes. We report that in T24 H-ras-transformed NIH 3T3 cells enhanced transcription contributes to the increased expression of OPN. Transient transfection studies, DNA-protein binding assays, and methylation protection experiments have identified a novel ras-activated enhancer, distinct from known ras response elements, that appears responsible for part of the increase in OPN transcription in cells with an activated RAS. In electrophoretic mobility shift assays, the protein-binding motif GGAGGCAGG was found to be essential for the formation of several complexes, one of which (complex A) was generated at elevated levels by cell lines that are metastatic. Southwestern blotting and UV light cross-linking studies indicated the presence of several proteins able to interact with this sequence. The proteins that form these complexes have molecular masses estimated at approximately 16, 28, 32, 45, 80, and 100 kDa. Because the approximately 16-kDa protein was responsible for complex A formation, we have designated it MATF for metastasis-associated transcription factor. The GGANNNAGG motif is also found in some other promoters, suggesting that they may be similarly controlled by MATF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7799957      PMCID: PMC231995          DOI: 10.1128/MCB.15.1.476

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Analysis of the rat JE gene promoter identifies an AP-1 binding site essential for basal expression but not for TPA induction.

Authors:  H T Timmers; G J Pronk; J L Bos; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

Review 2.  The ets gene family.

Authors:  A Seth; R Ascione; R J Fisher; G J Mavrothalassitis; N K Bhat; T S Papas
Journal:  Cell Growth Differ       Date:  1992-05

3.  Signal transduction. How receptors turn Ras on.

Authors:  F McCormick
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

Review 4.  Ras-responsive genes and tumor metastasis.

Authors:  A F Chambers; A B Tuck
Journal:  Crit Rev Oncog       Date:  1993

5.  Comparative analysis of two alternative first exons reported for the mouse osteopontin gene.

Authors:  E I Behrend; A F Chambers; S M Wilson; D T Denhardt
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  p21ras and protein kinase C function in distinct and interdependent signaling pathways in C3H 10T1/2 fibroblasts.

Authors:  A Krook; M J Rapoport; S Anderson; H Pross; Y C Zhou; D T Denhardt; T L Delovitch; T Haliotis
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

Review 7.  Non-nuclear oncogenes and the regulation of gene expression in transformed cells.

Authors:  D M Bortner; S J Langer; M C Ostrowski
Journal:  Crit Rev Oncog       Date:  1993

8.  Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding.

Authors:  R J Fisher; S Koizumi; A Kondoh; J M Mariano; G Mavrothalassitis; N K Bhat; T S Papas
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

9.  Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines.

Authors:  V L Morris; A B Tuck; S M Wilson; D Percy; A F Chambers
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

Review 10.  Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.

Authors:  D R Senger; C A Perruzzi; A Papadopoulos
Journal:  Anticancer Res       Date:  1989 Sep-Oct       Impact factor: 2.480

View more
  15 in total

1.  Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.

Authors:  P L Chang; T F Lee; K Garretson; C W Prince
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells.

Authors:  M Takemoto; M Kitahara; K Yokote; S Asaumi; A Take; Y Saito; S Mori
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer.

Authors:  Guoxin Zhang; Bin He; Georg F Weber
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

4.  Osteopontin overexpression in vascular smooth muscle cells transfected with the c-Ha-rasEJ oncogene.

Authors:  A R Parrish; T J Weber; K S Ramos
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-09       Impact factor: 2.416

5.  Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.

Authors:  Caroline Conway; Angana Mitra; Rosalyn Jewell; Juliette Randerson-Moor; Samira Lobo; Jérémie Nsengimana; Sara Edward; D Scott Sanders; Martin Cook; Barry Powell; Andy Boon; Faye Elliott; Floor de Kort; Margaret A Knowles; D Timothy Bishop; Julia Newton-Bishop
Journal:  Clin Cancer Res       Date:  2009-11-03       Impact factor: 12.531

6.  Expression of osteopontin and CD44 molecule in papillary renal cell tumors.

Authors:  Koviljka Matusan; Gordana Dordevic; Vladimir Mozetic; Ksenija Lucin
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

7.  Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing.

Authors:  Yanping Chen; Susan R Rittling
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Growth of v-src-transformed cells in serum-free medium through the induction of growth factors.

Authors:  Tiziana Deangelis; Andrew Quong; Andrea Morrione; Renato Baserga
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

9.  Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.

Authors:  Kerry A Whalen; Georg F Weber; Thomas L Benjamin; Brian S Schaffhausen
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

Review 10.  Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter.

Authors:  David T Denhardt; Devra Mistretta; Ann F Chambers; Shuba Krishna; Joseph F Porter; Srilatha Raghuram; Susan R Rittling
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.